Mastura Monif is an expert in Neurology at Alfred Health (Australia). As of October 2026, ScienceLeadR ranks Mastura Monif in the top 1% of experts worldwide for Encephalitis and Neuroinflammatory Diseases. Mastura Monif has authored 172 publications, the most recent in 2026. SLR score: 702 (community average: 125). How the SLR is computed.

LeadR Profile

Mastura Monif Alfred Health Australia
702 ScienceLeadR Reputation 702
Network Map

Neurology

Subspecialties: Immunology - Psychiatry - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2009 - 2026

Source: PubMed

Royal Melbourne Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 172

Citations

Citations: 2 675 1st author: 14 Last author: 76 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
How patients with neuromyelitis optica spectrum disease accumulate disability.
PMID 42847346 — multiple sclerosis, absenteeism, central nervous system diseases, cohort studies, neuromyelitis optica, demyelinating diseases
Mult Scler20260
Strategies for integrating artificial intelligence and cognitive assessment to predict disability progression in relapsing-remitting multiple sclerosis: A model development study.
PMID 42789556 — sclerosis, multiple sclerosis, intelligence, artificial intelligence, multiple sclerosis, relapsing-remitting
PLOS Digit Health20260
Patient-reported symptom burden after chimeric antigen receptor T-cell therapy.
PMID 42747063 — cells, receptors, antigen, receptors, chimeric antigen, therapeutics, t-lymphocytes, cognition, receptors, antigen, t-cell
Br J Haematol20260
Modern diagnosis and treatment of multiple sclerosis: advances, challenges, and future directions.
PMID 42660264 — sclerosis, multiple sclerosis, biomarkers, diagnosis, therapeutics, autoimmunity
Autoimmun Rev20260
The Imbalance Between Tumor Immunosurveillance and Tumor Immune Escape in Glioblastoma.
PMID 42619051 — cells, growth, tumor escape, neoplasms, cell biology, glioblastoma, monitoring, immunologic, immune evasion
Immunol Cell Biol20260

LeadR Networks

Main global connection map